HR 5402
Protecting America’s Life Saving Medicines Act of 2019
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Protecting America’s Life Saving Medicines Act of 2019 directs the Food and Drug Administration (FDA) to study drugs that are likely to be approved but haven’t yet been, focusing on high-risk, high-reward medications for serious diseases. The FDA will then create a list of these drugs and share it with the Treasury Department. Additionally, the bill establishes a 25% tax credit for clinical testing expenses incurred by companies developing these high-risk drugs, aiming to incentivize research into potentially life-saving treatments.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Fred Upton
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.